Evidence map›Paper›PMID 28507606›Full record

ArticleEpigenetics & chromatin2017

Transcription and chromatin determinants of de novo DNA methylation timing in oocytes.

Lenka Gahurova, Shin-Ichi Tomizawa, Sébastien A Smallwood, Kathleen R Stewart-Morgan, Heba Saadeh, Jeesun Kim, Simon R Andrews, Taiping Chen, Gavin Kelsey

Open access · goldAbstract read
In one paragraph

Article in Epigenetics & chromatin, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 104 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 7 countries.

Lenka Gahurova *Epigenetics Programme, Babraham Institute, Cambridge, CB22 3AT UK.
Shin-Ichi Tomizawa *Department of Histology and Cell Biology, School of Medicine, Yokohama City University, Yokohama, 236-0004 Japan.
Sébastien A SmallwoodEpigenetics Programme, Babraham Institute, Cambridge, CB22 3AT UK.
Kathleen R Stewart-MorganEpigenetics Programme, Babraham Institute, Cambridge, CB22 3AT UK.
Heba SaadehEpigenetics Programme, Babraham Institute, Cambridge, CB22 3AT UK.
Jeesun KimDepartment of Epigenetics and Molecular Carcinogenesis, The University of Texas M.D. Anderson Cancer Center, Smithville, TX 77030 USA.
Simon R AndrewsBioinformatics Group, Babraham Institute, Cambridge, CB22 3AT UK.
Taiping ChenDepartment of Epigenetics and Molecular Carcinogenesis, The University of Texas M.D. Anderson Cancer Center, Smithville, TX 77030 USA.
Gavin KelseyEpigenetics Programme, Babraham Institute, Cambridge, CB22 3AT UK.ORCID 0000-0002-9762-5634
Babraham Institute · GBThe University of Texas MD Anderson Cancer Center · USUniversity of Copenhagen · DKUniversity of Jordan · JOYokohama City University · JP

Funding

Biotechnology and Biological Sciences Research CouncilMedical Research Council G0800013Medical Research Council MR/K011332/1
6 · The paper itself

Abstract

backgroundGametogenesis in mammals entails profound re-patterning of the epigenome. In the female germline, DNA methylation is acquired late in oogenesis from an essentially unmethylated baseline and is established largely as a consequence of transcription events. Molecular and functional studies have shown that imprinted genes become methylated at different times during oocyte growth; however, little is known about the kinetics of methylation gain genome wide and the reasons for asynchrony in methylation at imprinted loci.

resultsGiven the predominant role of transcription, we sought to investigate whether transcription timing is rate limiting for de novo methylation and determines the asynchrony of methylation events. Therefore, we generated genome-wide methylation and transcriptome maps of size-selected, growing oocytes to capture the onset and progression of methylation. We find that most sequence elements, including most classes of transposable elements, acquire methylation at similar rates overall. However, methylation of CpG islands (CGIs) is delayed compared with the genome average and there are reproducible differences amongst CGIs in onset of methylation. Although more highly transcribed genes acquire methylation earlier, the major transitions in the oocyte transcriptome occur well before the de novo methylation phase, indicating that transcription is generally not rate limiting in conferring permissiveness to DNA methylation. Instead, CGI methylation timing negatively correlates with enrichment for histone 3 lysine 4 (H3K4) methylation and dependence on the H3K4 demethylases KDM1A and KDM1B, implicating chromatin remodelling as a major determinant of methylation timing. We also identified differential enrichment of transcription factor binding motifs in CGIs acquiring methylation early or late in oocyte growth. By combining these parameters into multiple regression models, we were able to account for about a fifth of the variation in methylation timing of CGIs. Finally, we show that establishment of non-CpG methylation, which is prevalent in fully grown oocytes, and methylation over non-transcribed regions, are later events in oogenesis.

conclusionsThese results do not support a major role for transcriptional transitions in the time of onset of DNA methylation in the oocyte, but suggest a model in which sequences least dependent on chromatin remodelling are the earliest to become permissive for methylation.

Indexed as

Transcription, GeneticAnimalsChromatinChromatin Assembly and DisassemblyCpG IslandsDNA (Cytosine-5-)-MethyltransferasesDNA MethylationFemaleGenomic ImprintingGerm CellsHistonesMiceOocytesOogenesisTranscriptomeChromatinDNA (Cytosine-5-)-MethyltransferasesHistonesDNA methylationHistone modificationsImprintingOocytesTranscription

Identifiers

PMID28507606
PMCPMC5429541
OpenAlexW2613703543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.